Summary

This article has explored neuropharmacology from the standpoint of the most important clinical conditions in the fields of psychiatry, neuropsychiatry, and neurology. Neuropharmacology contributes to these fields by bringing to bear the models of receptor-ligand interactions as one basis for the diseases upon which they focus. These models yield neuropharmacologic agents that can alter aberrant neurophysiological and neuro-chemical processes. Although many of the diseases upon which this article focused are not fully elucidated in terms of mechanism, ongoing neuropharmacologic research, by developing and testing more receptor-selective drugs, is slowly providing a means for piecing together their etiologies. Through a cyclical process, whereby neuropharmacologic agents are suggested by receptor models of disease, the receptor models are refined on the basis of the effects of the agents, and new agents are, thus, developed on the basis of receptor model refinements. Many of the diseases about which we know little in the year 2002 may be more treatable and possibly even "cured" in the years to come.

See Also the Following Articles

BEHAVIORAL PHARMACOLOGY • CATECHOLAMINES • CHEMICAL NEUROANATOMY • COGNITIVE PSYCHOLOGY, OVERVIEW • DEMENTIA • DEPRESSION • MANIC-DEPRESSIVE ILLNESS • MOOD DISORDERS • NEURO-BEHAVIORAL TOXICOLOGY • NEUROPSYCHOLOGICAL ASSESSMENT • PSYCHOACTIVE DRUGS • SCHIZOPHRENIA

Unraveling Alzheimers Disease

Unraveling Alzheimers Disease

I leave absolutely nothing out! Everything that I learned about Alzheimer’s I share with you. This is the most comprehensive report on Alzheimer’s you will ever read. No stone is left unturned in this comprehensive report.

Get My Free Ebook


Post a comment